Yüklüyor......
Evolocumab lowers LDL-C safely and effectively when self-administered in the at-home setting
Evolocumab has been shown to consistently reduce low-density lipoprotein cholesterol (LDL-C) across populations. The phase 3 studies included administration in the home-use and in-clinic settings but did not specifically evaluate the feasibility of home-use administration. Two clinical studies enrol...
Kaydedildi:
Yayımlandı: | Springerplus |
---|---|
Asıl Yazarlar: | , , , , , , , , , |
Materyal Türü: | Artigo |
Dil: | Inglês |
Baskı/Yayın Bilgisi: |
Springer International Publishing
2016
|
Konular: | |
Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4783317/ https://ncbi.nlm.nih.gov/pubmed/27066336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40064-016-1892-3 |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|